Adocia Seeks $200M From Eli Lilly For Alleged Confidentiality Breaches
(February 6, 2018, 1:32 PM EST) -- LYON, France — A French biopharmaceutical company on Feb. 6 announced that it asserted additional claims in an arbitration commenced against Eli Lilly & Co. in relation to its alleged misappropriation...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login